TCL Archive The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year April 20, 2012
TCL Archive Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34% June 28, 2013
TCL Archive Circulating Tumor Cells Predict Treatment Resistance In Study Of Metastatic Breast Cancer August 30, 2013
